Mood disorders: pharmacologic prevention of recurrences. National Institutes of Health Consensus Development Conference Statement.
D000341:Affective Disorders, Psychotic / Q000517:prevention & control*; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000517:prevention & control; D003866:Depressive Disorder / Q000517:prevention & control; D006801:Humans; D008094:Lithium / Q000627:therapeutic use*; D009316:National Institutes of Health (U.S.); D012008:Recurrence; D014481:United States
D000929:Antidepressive Agents, Tricyclic; D008094:Lithium